More: CohBar to Present at the BIO-Europe Conference
More: CohBar to Present at the BIO-Europe Conference
Original post:Zynerba Pharmaceuticals Presents Data Supporting FMR1 Methylation Status as a Correlate to Fragile X Syndrome Severity at the Virtual Joint 16th...
Here is the original post: VASCEPA® (Icosapent Ethyl) Found to Significantly Reduce Ischemic Events in Patients with Prior Percutaneous Coronary Intervention (PCI) in Post Hoc...
Continued here: Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
Read more: Valneva’s Chikungunya Vaccine Candidate Awarded EMA Prime Designation
See the original post here: Medicenna Provides MDNA55 rGBM Clinical Program Update Following Positive End of Phase 2 Meeting with the U.S. Food and Drug Administration (FDA)
See the article here: Adaptimmune Provides Full Contents of its SITC Abstract for the Phase 1 SURPASS Trial
See the original post here: MacroGenics Announces Flotetuzumab Publication in Blood Advances
Follow this link: Imara Announces First Patient Dosed in Forte Phase 2b Clinical Trial of IMR-687 in Beta-Thalassemia
More: Orchard Therapeutics Receives Positive CHMP Opinion for Libmeldy™ for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD)
Recent Comments